ACIU
AC Immune Ltd
2.50$
-5.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 53.2% | 43.6% | 111.0% | 161.3% | 615.5% | 45.7% | 385.5% | 6,597.7% | 1,533.3% | 368.9% | 229.1% | – | |
| 46.8% | 56.4% | -11.0% | -61.3% | -515.5% | 54.3% | -285.5% | -6,597.7% | 100.0% | -268.9% | -129.1% | 100.0% | |
| 53.2% | 43.6% | 111.0% | 161.3% | 615.5% | 45.7% | 385.5% | 6,597.7% | 1,533.3% | 368.9% | 229.1% | 1,579.5% | |
| 6.6% | 5.2% | 20.4% | 31.0% | 105.1% | 14.5% | 120.3% | 1,152.4% | 243.5% | 71.5% | 41.9% | 326.1% | |
| 64.6% | 52.4% | 145.0% | 211.3% | 788.8% | 14.0% | 111.5% | 8,369.7% | 1,900.4% | 93.4% | 62.7% | 2,027.3% | |
| 35.4% | 47.6% | -45.0% | -111.3% | -688.8% | 40.3% | -397.0% | -8,369.7% | -1,800.4% | -362.3% | -191.8% | -1,927.3% | |
| 0.0% | 0.1% | 1.1% | 0.7% | 4.6% | 1.7% | 1.2% | 61.5% | 9.0% | 1.2% | 0.5% | 5.3% | |
| 35.5% | 51.9% | -30.6% | -130.4% | -708.2% | 41.1% | -401.3% | -7,732.3% | -1,797.7% | -366.3% | -186.4% | -1,971.6% | |
| 0.1% | 4.2% | 15.6% | 0.7% | -15.3% | 1.7% | 1.2% | 0.3% | 0.3% | 0.1% | 0.0% | – | |
| 35.5% | 51.9% | -30.6% | -130.4% | -708.2% | 41.1% | -401.3% | -7,732.6% | -1,798.0% | -366.4% | -186.4% | -1,971.6% | |
| 36.4% | 48.4% | -29.3% | -111.3% | -690.2% | 41.5% | -387.0% | -7,415.9% | -1,728.7% | -350.2% | -178.0% | -1,896.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.